🔎 Trials Near Me

Početna › Gliom › Michigan

Kliničke studije za Gliom u državi Michigan

8 studija za Gliom traži sudionike na lokacijama u državi Michigan.

Gradovi u državi Michigan

Službeni tekst studije (engleski)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • C S Mott Children's Hospital, Ann Arbor
  • Children's Hospital of Michigan, Detroit
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
U tijeku regrutacijaFaza 1/2
12 Months – 21 Years · Oba spola · Ažurirano 1. lis 2026. · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Henry Ford Cancer- Detroit, Detroit
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaFaza 2
12 Months – 39 Years · Oba spola · Ažurirano 21. ruj 2026. · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaOpažajna studija
12 Months – 39 Years · Oba spola · Ažurirano 8. ruj 2026. · NCT05839379

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Henry Ford Hospital, Detroit
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaFaza 2
Od 3 do 39 godina · Oba spola · Ažurirano 24. kol 2026. · NCT05096481

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaFaza 2
12 Months – 39 Years · Oba spola · Ažurirano 29. svi 2026. · NCT05843253

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

  • Henry Ford Health System, Detroit
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 16. pro 2025. · NCT05686798

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.